Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Asset Resilience Ratio
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd asset resilience ratio. Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) has an Asset Resilience Ratio of -8.30% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Gansu Longshenrongfa Pharmaceutical Indu liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (None–None)
Asset resilience ratio of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd from None to None. This chart shows how Gansu Longshenrongfa Pharmaceutical Industry Co Ltd's Asset Resilience Ratio has changed over time. Read debt load of Gansu Longshenrongfa Pharmaceutical Indu for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Gansu Longshenrongfa Pharmaceutical Industry Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Gansu Longshenrongfa Pharmaceutical Indu balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥-109.82 Million | -8.3% |
| Total Liquid Assets | CN¥-109.82 Million | -8.30% |
Asset Resilience Insights
- Limited Liquidity: Gansu Longshenrongfa Pharmaceutical Industry Co Ltd maintains only -8.30% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Industry Peers by Asset Resilience Ratio
Compare Gansu Longshenrongfa Pharmaceutical Industry Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Galderma Group N
SW:GALD |
Drug Manufacturers - Specialty & Generic | 3.56% |
|
Enzymatica publ AB
ST:ENZY |
Drug Manufacturers - Specialty & Generic | 22.17% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Asset Resilience Ratio by Year (None–None)
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd asset resilience ratio by year from None to None. The table below shows the annual Asset Resilience Ratio data for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| No yearly data available. | ||||
About Gansu Longshenrongfa Pharmaceutical Industry Co Ltd
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally. It is also involved in the cultivation, processing, and sales of chemical drugs and medicinal herbs, as well as pharmaceutical distribution, testing, and inspection services. The company was founded in 2002… Read more